Efficacy of a synbiotic containing Bacillus coagulans in the treatment of irritable bowel syndrome: a randomized placebo-controlled trial
Rogha M, Esfahani MZ, Zargarzadeh AH
Published in Gastroenterology and Hepatology from Bed to Bench
Methodology
Randomized, placebo-controlled trial of a B. coagulans-containing synbiotic in patients with IBS.
Key Findings
Abdominal pain and bloating improved significantly in the synbiotic group versus placebo, with no difference in some secondary measures.
Conclusions
A B. coagulans synbiotic reduced key IBS symptoms in this trial.
Limitations
Synbiotic formulation prevents attribution to the spore organism alone; modest sample.
Supplements Studied
A B. coagulans synbiotic reduced key IBS symptoms in this trial.
Abdominal pain and bloating improved significantly in the synbiotic group versus placebo, with no difference in some secondary measures.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.